473 filings
Page 5 of 24
3
wy2t8w4f
1 Dec 17
GT Biopharma / Raymond W. Urbanski ownership change
12:00am
4
7yvllwfvnblbsbl341i
1 Dec 17
GT Biopharma / Tony Cataldo ownership change
12:00am
3
0d54jq6e2tyffnlpjd
1 Dec 17
GT Biopharma / Mark J Silverman ownership change
12:00am
3
zpgdbvw0
1 Dec 17
GT Biopharma / Kathleen Clarence-Smith ownership change
12:00am
4
6hctzmkt
1 Dec 17
GT Biopharma / Steven W Weldon ownership change
12:00am
8-K
wh5vnz
16 Nov 17
Departure of Directors or Certain Officers
12:00am
SC 13G
u0u7zu
14 Nov 17
GT Biopharma, Inc.
12:00am
8-K
f2s1l
12 Oct 17
GT Biopharma Announces Stock Sales Agreement with Holders of Converted Securities
12:00am
SC 13G/A
m5maygn
10 Oct 17
GT Biopharma, Inc.
12:00am
SC 13G/A
f93dkr
20 Sep 17
GT Biopharma, Inc.
12:00am
D
0jtrv ofq
14 Sep 17
$4.54M in equity / debt, sold $4.54M, 9 investors
12:00am
8-K
5sqyjjxij0t 41x9a
5 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
q496cl
25 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am
RW
y48w1bp
24 Jul 17
Registration withdrawal request
12:00am
8-K
bkoxb7gks fvv1
26 Jun 17
Oxis Agrees to Acquire Georgetown Translational Pharmaceuticals, Appoints New Chief Executive Officer and Chief Medical Officer
12:00am
DEF 14C
n8d799 yj
12 May 17
Information statement
12:00am
UPLOAD
q41ta4r
9 May 17
Letter from SEC
12:00am
PRER14C
txej5u 7akjgt
5 May 17
Preliminary revised information
12:00am